Recent updates regarding the management and treatment of pneumonia in pediatric patients: a comprehensive review
- PMID: 40764862
- DOI: 10.1007/s15010-025-02605-w
Recent updates regarding the management and treatment of pneumonia in pediatric patients: a comprehensive review
Abstract
Pneumonia remains one of the leading causes of illness and death among children, particularly in low- and middle-income countries. This review presents a comprehensive update on pediatric pneumonia, covering recent advances in etiology, clinical presentation, diagnostic tools, treatment strategies, and prevention efforts. We explore both traditional and emerging diagnostic methods, including the use of biomarkers like C-reactive protein and procalcitonin, molecular testing, and point-of-care lung ultrasound. Treatment approaches are discussed in detail, with a focus on appropriate antibiotic use, antiviral and antifungal therapies, supportive care such as oxygen therapy and fluid management, and newer interventions like high-flow nasal cannula therapy. Preventive measures, including the introduction and global rollout of pneumococcal, influenza, and RSV vaccines, are also emphasized. In addition, the review highlights ongoing challenges such as antimicrobial resistance, healthcare disparities, and the limited accessibility of advanced diagnostic tools in resource-poor settings. Finally, we outline research gaps and stress the need for strong public health policies, global collaboration, and continued innovation to reduce the burden of pediatric pneumonia and improve outcomes for children worldwide. Highlights Pediatric pneumonia continues to cause high morbidity and mortality, especially in low- and middle-income countries. Advances in diagnostics, including lung ultrasound, procalcitonin testing, and molecular tools, have improved early detection. Rational antibiotic use and stewardship programs are vital to addressing rising antimicrobial resistance. New preventive tools, such as pneumococcal, influenza, and RSV vaccines, play a key role in reducing disease burden. Health disparities and limited access to care remain major challenges, highlighting the need for policy reforms and global health initiatives.
Keywords: Antibiotic resistance; Clinical presentation; Management strategies; Molecular diagnostics; Pediatric pneumonia; Supportive care.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests. Ethics approval and consent to participate:: Not applicable. Consent for publication:: Not applicable.
References
-
- Lim W. S. (2022). Pneumonia—Overview. Encyclopedia of Respiratory Medicine, 185–197. https://doi.org/10.1016/B978-0-12-801238-3.11636-8
-
- Rudan I, O’Brien KL, Nair H, Liu L, Theodoratou E, Qazi S, Lukšić I, Fischer Walker CL, Black RE, Campbell H, Child Health Epidemiology Reference Group (CHERG). Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health. 2013;3(1):010401. https://doi.org/10.7189/jogh.03.010401 . - DOI - PubMed - PMC
-
- Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 2008;86(5):408–16. https://doi.org/10.2471/blt.07.048769 . - DOI - PubMed - PMC
-
- Howie SRC, Murdoch DR. Global childhood pneumonia: the good news, the bad news, and the way ahead. Lancet Glob Health. 2019;7(1):e4–5. https://doi.org/10.1016/S2214-109X(18)30446-7 . - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials